TEVA PHARMACEUTICAL INDUSTRIES LIMITED Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED stock issued during period, value, new issues for the quarter ending 2024-12-31 was $0.00.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED stock issued during period, value, new issues for the quarter ending 2024-09-30 was $0.00.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED stock issued during period, value, new issues for the quarter ending 2024-06-30 was $0.00.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED stock issued during period, value, new issues for the quarter ending 2024-03-31 was $1.00M.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED stock issued during period, value, new issues for fiscal 2025 was $1.00M, a 0.00% change from fiscal 2024.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED stock issued during period, value, new issues for fiscal 2024 was $1.00M.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED stock issued during period, value, new issues for fiscal 2022 was $1.00M.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED stock issued during period, value, new issues for fiscal 2020 was $1.00M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-12-31 | $1.00M 10-K · filed 2026-02-03 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03 | $1.00M 10-K · filed 2026-02-03 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | |
| 2024-03-31 | $1.00M 10-Q · filed 2025-05-07 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-05 | $1.00M 10-K · filed 2025-02-05 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | |
| 2022-03-31 | $1.00M 10-Q · filed 2023-05-10 | |
| 2020-12-31 | $1.00M 10-K · filed 2022-02-09 | |
| 2018-12-31 | -$52.00M 10-K · filed 2021-02-10 | |
| 2016-12-31 | $5.39B 10-K · filed 2019-02-19 | |
| 2015-12-31 | $3.29B 20-F · filed 2017-02-15 |